ILCF Grant Recipient Spotlights

Featured Spotlight

Tejas Patil, MD

Assistant Professor, Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus

The ILCF has been a very important stepping stone in my career. I am very thankful for receiving the John Fisher Legacy Fellowship, aimed at improving outcomes for patients diagnosed with early-stage lung cancer. This award has provided me the foundation to develop a sophisticated platform to address very granular level questions regarding patterns of recurrence, molecular features associated with relapse, and optimal surveillance strategies. I intend to build on this platform to continue my work in helping patients with lung cancer.

Kellie Smith, PhD

Assistant Professor of Oncology, Johns Hopkins University

The ILCF Research Grant will all my group to better understand the immune parameters governing earl-stage lung cancer. This will enable us to identify novel targets for neoadjuvant and adjuvant therapies, with a goal of delaying or preventing relapse after surgical resection. Additionally, the data generated under this grant will allow us to generate new hypotheses that can be used for larger applications in the future.

Biagio Ricciuti, MD

With the support of the ILCF, we have demonstrated that a genomically defined subset of lung cancers harboring mutations in genes involved in DNA damage repair (DDR) derive improved clinical outcomes with PD-(L)1 blockade.

Read Spotlight

Wencai Zhang, MD

With the support, I can utilize cutting-edge metabolomic and whole transcriptomic approaches to advance our understanding of the interaction of metabolite-miRNA in driving tumor initiation.

Read Spotlight

Grant Recipient

Hua Zhang, MD

"My career goal is leading a multidisciplinary research laboratory focused on addressing challenges in the treatment of lung cancer."

Read Spotlight

Grant Recipient

Alice Berger, MD

"Ultimately my goal is to provide new therapeutic options for patients with lung cancer."

Read Spotlight

Grant Recipient

Aaron C. Tan, MD

"I hope my future research can build on this foundation, to drive innovation, generate novel data, and ultimately improve outcomes for patients."

Read Spotlight

Support Researchers!

People who are diagnosed with lung cancer gain hope through improved treatment options resulting from scientific advances. The International Lung Cancer Foundation exists to fund innovative research that leads to scientific advances in the detection and treatment of lung cancer and other thoracic malignancies. We need your help to fund our next round of researchers and their innovative projects. Despite being the leading cause of cancer death, lung cancer receives far less government research funding than any other cancer, so research support from corporations, foundations, and individual donors is crucial.

Fund Research Now